News

Filter

Current filters:

MoxDuo

Further FDA delay for QRxPharma's MoxDuo

29-08-2013

Australia-based QRxPharma (ASX: QRX) has received a complete response letter from the US Food and Drug…

MoxDuoPharmaceuticalQRxPharmaRegulation

Planned FDA review of QRxPharma's MoxDuo delayed to allow assessment of new data

26-06-2013

Australia-based QRxPharma (ASX: QRX) today (June 26) advised that the planned July 17 US Food and Drug…

MoxDuoNeurologicalNorth AmericaPharmaceuticalQRxPharmaRegulation

US FDA sets PDUFA date for QRxPharma's resubmitted MoxDuo NDA

15-03-2013

Australia-based QRxPharma (ASX: QRX) says that the US Food and Drug Administration has set August 26,…

MoxDuoNeurologicalNorth AmericaPharmaceuticalQRxPharmaRegulation

FDA delays approval of QRxPharma's pain drug MoxDuo

29-06-2012

The US Food and Drug Administration has issued a Complete Response Letter (CRL) regarding the New Drug…

ActavisMoxDuoNeurologicalNorth AmericaPharmaceuticalQRxPharmaRegulationWatson Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top